Inflammation, Hormones, and the Truth About NAD: Longevity That Feels Steady, Not Extreme with Dr. Nichola Conlon

Dr. Nichola Conlon, molecular biologist, NAD⁺ researcher, and CEO of Nuchido (code: BIOHACKINGBRITTANY), unpacks inflammation, mitochondrial energy, and biological age through a clear, female-first lens.  She discusses how NAD⁺ decline intersects with hormones and stress, why over-fasting and all-out training can backfire, and when to prioritize nervous-system safety in seasons like postpartum and perimenopause.  Expect practical ways to test what matters, calm hidden inflammation, and switch on your cells' own NAD⁺ production—so longevity feels steady, not extreme. Join my 12 Holiday Rituals Giveaway for a chance to win part of $5,500+ USD in wellness prizes. Open until December 24th! WE TALK ABOUT:  05:40 - The shift from lifespan to healthspan and why women lose two decades to chronic disease 08:20 - Healthspan defined: Living longer healthier, not just longer 11:45 - Why aging is reversible at the cellular level 13:25 - Biological vs. chronological age and why the gap matters 16:35 - Why inflammation-based metrics can be more actionable 20:15 - How pregnancy, stress, and perimenopause affect inflammation 23:20 - NAD⁺ 101: Energy, repair, and resilience for women's bodies 25:45 - The NAD decline curve (and how lifestyle accelerates or slows it) 33:05 - Inside Nuchido's approach: Switch on your own NAD production 38:20 - What's next for NAD research and everyday habits that help 43:15 - Nature + botanicals: Honoring biology in a modern world RESOURCES: Free gift: Download my hormone-balancing, fertility-boosting chocolate recipe. Explore my luxury retreats and wellness events for women. Shop my faves: Check out my Amazon storefront for wellness essentials. Nuchido website (code: BIOHACKINGBRITTANY) and Instagram  Join my 12 Holiday Rituals Giveaway before December 24th LET'S CONNECT: Instagram, TikTok, Facebook Shop my favorite health products Listen on Spotify, Apple Podcasts, YouTube Music

There are no comments yet.

Please log in to write the first comment.